Eighteen months ago an adult patient presented to my office
for an Invisalign consult. After being told he was an excellent
candidate, he chose not to begin treatment. Last month this
patient revisited my website, saw the PROPEL Orthodontics
logo and clicked on the link to learn about how it can be used
to facilitate tooth movement and decrease length of treatment.
He returned to my office for a second consult and had his
impressions taken that day. The patient stated that had it not
been for the possibility of getting the PROPEL treatment and
learning about it from my website, he would not have returned
for orthodontic care.
This affirmed for me the huge potential benefit of PROPEL.
The treatment attracts patients who are unwilling to accept a
prolonged treatment time. PROPEL has increased my practice's
bottom line by shortening treatment time, allowing me to treat
additional patients, finishing challenging or "stuck"cases and
attracting patients who would not otherwise accept treatment.
Background
Micro-Osteoperforation stimulates cytokine activity accelerating
alveolar bone remodeling. This new device developed and
patented by PROPEL can be used in a simple, in-office procedure
to stimulate alveolar bone remodeling. The PROPEL device was
developed from research out of the NYU Department of
Orthodontics and has been commercially available since fall 2012.
In using a patient's own biology to facilitate tooth movement, PROPEL
does so by creating micro-osteoperforations. This treatment
stimulates the local inflammatory response, which induces cytokine
activity, thereby stimulating faster bone remodeling.1 An increase in
bone remodeling allows teeth to be moved to the desirable location
at a faster rate. Research shows that this increased inflammatory
response returns to normal levels in six to eight weeks, therefore, the
patient must be re-treated every six to eight weeks2 until desired
tooth movements are achieved. PROPEL is an FDA Class 1, 510k-exempt
medical device to be disposed of after a single use.
The treatment is performed chairside with a potent topical gel
or a few drops of a local infiltrative anesthetic. These micro-osteoperforations
are created through the mucosa and the cortical plate
into cancellous bone.
Advantages
The PROPEL System has several tangible advantages. Given
its FDA designation, it can be used with any appliance or clear
aligner system. Secondly, the treatment does not have to be
referred out to other specialists, increasing the likelihood of
acceptance by patients. Additionally, unlike more extensive and
expensive surgical techniques, there is no recovery time. As a
result, patients can go about their daily activities with no downtime
or disruption to their usual routines.
PROPEL can be applied in a targeted, doctor-controlled fashion
rather than acting on the whole dentition. Doctors maintain
control of treatment mechanics and do not need to monitor any
additional patient compliance. Because it is a targeted treatment
there is no concern of loss of anchorage or TADs loosening from
vibration pulses. Likewise, if trying to correct an occlusal cant to
the smile, doctors can target the teeth that are off the occlusal
plane and in need of correction. In such cases, being able to
"soften"the alveolar bone by differentially increasing the bone
remodeling in the desired area helps eliminate the unwanted intrusion
of the "good"side in these cases with occlusal cants. Stubborn
rotations are also an excellent indication to use PROPEL.
In my PROPEL/Invisalign cases I have patients switch their
aligners weekly, instead of biweekly. There is no need to modify
the rate of tooth movement on ClinCheck. I have relied on the
optimized velocity as prescribed by Align and use routine clinical
judgment to modify attachment design and the path teeth
take to get to their final positions.
The PROPEL system is reasonably priced. In volume, the
devices cost about $100 each. While each case is different
and might require a different number of treatments,
an average case can be expected to require one
to three treatments. My experience has shown a four first bicuspid
extraction case treated with braces required five devices, while
closing down an anterior open bite with aligners required
four. When targeting an occlusal cant or single rotation, you
might only need one or two devices. This is an increase in overhead
of $100-$400. This incremental cost can easily be passed along to
the patient. Most orthodontic patients spread out their total case fee
into monthly payments over the course of treatment. In my experience,
little resistance to this additional fee has been seen.
Applying These Tangible Benefits to the
Bottom Line
Simply said and easily understood, faster treatment means
reducing overall chairtime for each case. That can easily be translated
to more profitability per visit.
The reality is that over 90 percent of offices surveyed by the
McGill Advisory Newsletter in May, 2010, are not operating at full
capacity. Openings in the schedule can be seen as opportunities as
orthodontists utilize multiple internal and external marketing
strategies to drive new patients to the practice as well as increase
case acceptance.
The trend since 2004 is that orthodontists are spending an
average of three percent of their gross revenue in practice promotion
to help fill these holes in the schedule. It could be argued that
part of the PROPEL expense is not only the device itself, but also
a marketing expense because the orthodontist can use PROPEL's
cutting-edge technology to attract new patients and help convert
otherwise reluctant patients.
Profitability Examples
For the Doctor: A patient presented with a 10mm molar
space that he wanted to close in order to avoid an implant. This
case was completed in five months with five visits instead of the
usual 12 visits this type of case would normally have taken. Five
months is roughly the same time it takes an implant to heal and
integrate with the bone before the need to uncover and heal prior
crown fabrication, which takes an additional two to three months.
Using conservative estimates of $200 per visit instead of the
industry standard of $300 per visit, the doctor has saved $1,400
(seven saved visits x $200/visit).
The patient received three micro-perforation activations using
PROPEL. PROPEL cost $100 each for a total cost of $300.
Without charging the patient for the device the doctor saved
$1100. If the doctor had included a $500 additional case fee, the
profit would increase to $1,900.
For the Patient: The ability to close this space in a predictable
manner, where the patient can avoid a bone graft and implant
allows the patient to avoid costly and painful dental work. The cost
of a bone graft, implant and restoration could range from $4,000
to $10,000. Having the patient pay an additional case fee of $500
will still save the patient thousands of dollars.
Reducing treatment time for patients has been an industry
goal due to patient and orthodontist demand. Besides the cost of
treatment, patients take time from work and school to attend multiple appointments. These appointments incur significant indirect
costs. Patients spend an average of $654 additional dollars traveling
to and from their appointments during a two-year treatment.3
Reducing the number of these multiple office visits by 50-60 percent
will save both time and money.
There are three main ways to manage the incremental cost of
adding PROPEL to your armamentarium. First, the clinician can
choose to not charge because of the savings in chairtime and the
inherent value in improving the predictability of simple and difficult
cases; second, implement two case fees, a regular case fee
and a premium for an accelerated case fee; or third, simply
charge the patient per PROPEL treatment. Orthodontists can
use all of the revenue options depending on the clinical scenario
or individual patient.
The PROPEL System augments a patient's own biology to
facilitate tooth movement. PROPEL bridges the gap between the
basic science of orthodontic tooth movement and application of
this science in the private practice setting to address the patient's needs and desires. It is this sound foundation that has allowed
PROPEL's easy acceptance into private practice with doctors
quickly realizing the clinical and profitability benefits.
References
- Teixeira CC, Khoo E, Tran J, Chartres I, Liu Y, Thant LM, et al. (2010). Cytokine expression and accelerated tooth movement. J Dent Res 89:1135-1141
- Khoo E, Tran J, Raptis M, Teixeira CC, Alikhani M (2011). Accelerated Orthodontic Treatment
- Richmond, Stephen. “Guest Editorial The Need for Cost-effectiveness.” Journal of orthodontics 27.3
(2000): 267-269.
Author's Bio |
Dr. James Reynolds earned his dental degree from the University of Michigan and his master's degree in orthodontics from the University of Detroit-Mercy.
He is a diplomate of the American Board of Orthodontics and the first orthodontist to include an Insignia case in his ABO certification examination. In
private practice in Novi and Rochester, Michigan, Dr. Reynolds is a featured speaker on the latest technologies in orthodontics throughout the U.S.
|
|